Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: Formulation and gender differences

Michael W. Jann, Troy L. ZumBrunnen, Srini N. Tenjarla, Earl S. Ward, Donald J. Weidler

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: Formulation and gender differences'. Together they form a unique fingerprint.

Medicine & Life Sciences